Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

BACKGROUND: Standard clinical parameters cannot accurately differentiate indolent from aggressive prostate cancer. Our previous work showed that immunohistochemical (IHC) Ki-67 improved prediction of prostate cancer death in a cohort of conservatively treated clinically localised prostate cancers di...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, G, Yang, Z H, Kudahetti, S, Møller, H, Scardino, P, Cuzick, J, Berney, D M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566811/
https://www.ncbi.nlm.nih.gov/pubmed/23329234
http://dx.doi.org/10.1038/bjc.2012.598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566811/
https://www.ncbi.nlm.nih.gov/pubmed/23329234
http://dx.doi.org/10.1038/bjc.2012.598

Ejemplares similares